Nawaz Shahid, Janiad Sara, Fatima Aiman, Saleem Maira, Fatima Urooj, Ali Asad
Institute of Microbiology and Molecular Genetics, University of the Punjab, Lahore, Pakistan.
Department of Microbiology and Molecular Genetics, The Women University Multan, Multan, Pakistan.
Infect Disord Drug Targets. 2024;24(4):58-66. doi: 10.2174/0118715265271109231129112515.
Since the commencement of Corona Virus Disease 2019 (COVID-19) pandemic, which has resulted in millions of mortalities globally, the efforts to minimize the damages have equally been up to the task. One of those efforts includes the mass vaccine development initiative targeting the deadly Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). So far, vaccines have tremendously decreased the rate of transmission and infection in most parts of the world. However, the repeated resurgence of different types of mutated versions of the virus, also known as variants, has somehow created uncertainties about the efficacies of different types of vaccines. This review discusses some of the interesting SARS-CoV-2 features, including general structure, genomics, and mechanisms of variants development and their consequent immune escape. This review also focuses very briefly on antigenic drift, shift, and vaccine-developing platforms.
自2019年冠状病毒病(COVID-19)大流行开始以来,全球已导致数百万人死亡,为尽量减少损失所做的努力也同样不遗余力。其中一项努力包括针对致命的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的大规模疫苗研发倡议。到目前为止,疫苗已极大地降低了世界上大部分地区的传播率和感染率。然而,该病毒不同类型变异版本(也称为变种)的反复出现,在某种程度上给不同类型疫苗的效力带来了不确定性。本综述讨论了一些有趣的SARS-CoV-2特征,包括一般结构、基因组学、变种产生机制及其随之而来的免疫逃逸。本综述还非常简要地关注了抗原漂移、抗原转变和疫苗研发平台。